A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Spectinomycin
Bambuterol
The risk or severity of hypertension can be increased when Bambuterol is combined with Midomafetamine.
Spectinomycin
Choline magnesium trisalicylate
The risk or severity of hypertension can be increased when Choline magnesium trisalicylate is combined with Midomafetamine.
Spectinomycin
Salsalate
The risk or severity of hypertension can be increased when Salsalate is combined with Midomafetamine.
Spectinomycin
Magnesium salicylate
The risk or severity of hypertension can be increased when Magnesium salicylate is combined with Midomafetamine.
Spectinomycin
Ephedra sinica root
The risk or severity of hypertension can be increased when Ephedra sinica root is combined with Midomafetamine.
Spectinomycin
Pirbuterol
The risk or severity of hypertension can be increased when Pirbuterol is combined with Midomafetamine.
Spectinomycin
Lumiracoxib
The risk or severity of hypertension can be increased when Lumiracoxib is combined with Midomafetamine.
Spectinomycin
Olsalazine
The risk or severity of hypertension can be increased when Olsalazine is combined with Midomafetamine.
Spectinomycin
Rescinnamine
The risk or severity of hypertension can be increased when Rescinnamine is combined with Midomafetamine.
Spectinomycin
Arbutamine
The risk or severity of hypertension can be increased when Arbutamine is combined with Midomafetamine.
Spectinomycin
Balsalazide
The risk or severity of hypertension can be increased when Balsalazide is combined with Midomafetamine.
Spectinomycin
Salbutamol
The risk or severity of hypertension can be increased when Salbutamol is combined with Midomafetamine.
Spectinomycin
Oxaprozin
The risk or severity of hypertension can be increased when Oxaprozin is combined with Midomafetamine.
Spectinomycin
Fosphenytoin
The therapeutic efficacy of Fosphenytoin can be decreased when used in combination with Midomafetamine.
Spectinomycin
Ioflupane I-123
Midomafetamine may decrease effectiveness of Ioflupane I-123 as a diagnostic agent.
Spectinomycin
Thalidomide
Midomafetamine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Spectinomycin
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Midomafetamine.
Spectinomycin
Suvorexant
Midomafetamine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Spectinomycin
Sodium oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Midomafetamine.
Spectinomycin
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Midomafetamine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3